PALATINE, IL--(Marketwired - October 28, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that the Company plans to report financial results for the third quarter 2014 following the close of financial markets on Monday, November 3, 2014.
Inc. (NASDAQ: PRFT), a leading information technology and management
consulting firm serving Global 2000 and other large enterprise customers
throughout North America, today announced it will serve as a Star
Sponsor and exhibit financial services banking risk and compliance
solutions at Money20/20 .
By Barbara Kollmeyer and Jennifer Booton, MarketWatch
NEW YORK (MarketWatch) -- Analysts are shuddering at Twitter Inc.'s declining user engagement, and they are warning it could have a major implication for the company long term.
Fuel (NASDAQ: FUEL), a leading provider of artificial intelligence
(AI) advertising and marketing solutions for global agencies and brands,
today announced that Executive Vice President and General Manager, John
Nardone, will speak during a keynote session at ad:tech New York on
Wednesday, November, 5, 2014.
Magellan Health, Inc. (NASDAQ: MGLN) today announced that members of its
senior management team will participate in the Barclays Select Series
2014: SMID Cap Conference on Wednesday, November 12, 2014 at the
Barclays headquarters in New York City.
Sign-up for Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock investment picks
Fuel Tech, Inc. (NASDAQ: FTEK), a world leader in advanced engineering
solutions for the optimization of combustion systems for utility and
industrial customers, announced today that it will issue its financial
results for the third quarter ended September 30, 2014 on Thursday,
November 6, 2014 after the stock market closes.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.